barking up the wrong forrest

I feel that some people on this forum are missing the point of the latest CEO Investor Presentation.

There have been many claims that the company have done nothing but highlight the product, have said nothing that we didn't already know, and that the market hasn't reacted etc...

This is true. The market wasn't meant to.

This was a presentation to investors. To people who are unaware of AVH and it's product. Of course they need to know what it is, what the potential is, how it works. The photos and stats in the presentation answer all of these questions. It was a perfectly efficient presentation for the purpose.

To inform potential investors of everything AVH is and can do.

"the market doesn't care"

Of course the market doesn't care.... the market already know of AVH's potential. It's a known quantity on the ASX among medical investors... but it is not a known quantity in the US.... and this is why BD is presenting there. He has turned this company around and he is gathering support where it matters... the US... building up to FDA approval... in the country which has the most media about their soldiers being killed and injured, away from home shores, due to a skeptical and somewhat aggressive foreign policy I admit... but this is exactly why the D.o.D. are financing trials... because they believe the technology will pass too FDA phase three trials...

Do you seriously think the D.o.D. which is financed by the US Govt would pay millions of dollars to have an Australian medical company fail the trial?

They want this to pass. It's a solid proven product. It has passed in Eurpoe, China, and in Australia... it's not unreasonable to expect it to get the FDA approval which even he most repetitively negative posters have agreed is the key...

We're on course.